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Abstract
Background: In 2006, Spain implemented a national smoke-free legislation that prohibited smoking in enclosed public
places and workplaces (except in hospitality venues). In 2011, it was extended to all hospitality venues and selected outdoor
areas (hospital campuses, educational centers, and playgrounds). The objective of the study is to evaluate changes in
exposure to secondhand smoke among the adult non-smoking population before the first law (2004-05) and after the
second law (2011–12).
Methods: Repeated cross-sectional survey (2004–2005 and 2011–2012) of a representative sample of the adult ($16 years)
non-smoking population in Barcelona, Spain. We assess self-reported exposure to secondhand smoke (at home, the
workplace, during leisure time, and in public/private transportation vehicles) and salivary cotinine concentration.
Results: Overall, the self-reported exposure to secondhand smoke fell from 75.7% (95%CI: 72.6 to 78.8) in 2004-05 to 56.7%
(95%CI: 53.4 to 60.0) in 2011–12. Self-reported exposure decreased from 32.5% to 27.6% (215.1%, p,0.05) in the home,
from 42.9% to 37.5% (212.6%, p = 0.11) at work/education venues, from 61.3% to 38.9% (236.5%, p,0.001) during leisure
time, and from 12.3% to 3.7% (269.9%, p,0.001) in public transportation vehicles. Overall, the geometric mean of the
salivary cotinine concentration in adult non-smokers fell by 87.2%, from 0.93 ng/mL at baseline to 0.12 ng/mL after
legislation (p,0.001).
Conclusions: Secondhand smoke exposure among non-smokers, assessed both by self-reported exposure and salivary
cotinine concentration, decreased after the implementation of a stepwise, comprehensive smoke-free legislation. There was
a high reduction in secondhand smoke exposure during leisure time and no displacement of secondhand smoke exposure
at home.
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Introduction
Exposure to secondhand smoke (SHS) has been causally
associated with many adverse health effects[1]. Worldwide, it
has been estimated that, in 2004, exposure to SHS was responsible
for 379,000 deaths due to ischemic heart disease, 21,400 deaths
due to lung cancer, 165,000 due to lower respiratory infections,
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and 36,900 due to asthma[2]. In Spain, between 1228 and 3237
deaths due to lung cancer and ischemic heart diseases have been
attributed to SHS exposure[3].
Exposure to SHS can occur in different settings, including in the
home, at the workplace, in other private and public places (bars,
restaurants, cafes, etc.), and inside public and private transport
vehicles. Questionnaires, biomarkers, and airborne markers have
been used to evaluate SHS among non-smokers. The prevalence
of SHS exposure in adult non-smokers varies considerably,
depending on the country, the development of the tobacco
epidemic[4], the comprehensiveness of smoke-free legislation, and
the location of exposure to SHS. Worldwide, 33% of male non-
smokers and 35% of female non-smokers were exposed to SHS in
2004[2]. In Spain, 75% of the adult non-smoking population was
exposed to SHS in 2006; of those, 26.4% was exposed at home
and 39.8% at work or an educational venue[5]. In Barcelona, in
the period of 2004–2005, the prevalence of self-reported exposure
to SHS among non-smokers in all settings was similar to that of the
whole country[6].
On the 1st of January, 2006, a smoke-free legislation (Law 28/
2005) was implemented in Spain to protect the health of non-
smokers. The legislation banned smoking in all public and work
places, with some exceptions in hospitality venues (no ban in
venues of less than 100 m2, and ‘smoking areas’ were allowed in
venues over 100 m2)[7]. Some previous studies evaluated the
impact of that law and showed important reductions in the
exposure to SHS at the workplace[8], but no significant changes
occurred either at home or during leisure time[9]; furthermore,
and importantly, exposure to SHS was not reduced in bars or
restaurants[8,10,11]. Due to the evidence provided by those
evaluations, and after intensive advocate work, the law was
amended[12]. On the 2nd of January, 2011, a new legislation (Law
42/2010) was established to amend Law 28/2005. The new
Spanish legislation extended the smoking ban to all hospitality
venues (bars, cafes, pubs, restaurants, discos, and casinos) without
exception,[13] and extended the ban to some outdoors areas,
including hospital premises, educational campuses, and play-
grounds. The law included economic penalties for infringements
and its enforcement is a responsibility of the regional and local
health authorities. After the implementation of the new law, SHS
levels (measured as the quantities of airborne nicotine and PM2.5)
have decreased more than 90% in hospitality venues[14,15].
However, the impact of the more restrictive smoke-free legislation
has not been assessed for SHS exposure in the general population.
The objective of this study was to evaluate whether a
measurable change in SHS exposure could be detected in the
adult non-smoking population with the implementation of the
stepped Spanish smoke-free legislation. We compared SHS
exposure measurements (self-report data and levels of salivary
cotinine) before the first law (2004–05) and after the second law
(2011–12) legislation.
Methods
Study design and selection of study participants
This study had a repeated cross-sectional design. We included a
representative, random sample of the population of Barcelona
(Spain). Surveys were conducted before and after the implemen-
tation of smoke-free legislation. The pre-legislation data were
obtained between March 2004 and December 2005. We used the
same strategy to collect the post-legislation data between June
2011 and March 2012. Detailed information about the pre-
legislation survey (sampling, face-to-face questionnaire, saliva
collection, and cotinine analysis) has been provided in previous
studies[6,16].
In brief, for each survey, we determined a sample size of 1,560
people with standard procedures (a error of 5%, beta error of
20%, and 20% losses for independent samples). The pre-legislation
survey (years 2004–05), included a final sample of 1,245
individuals and the post-legislation survey included a final sample
of 1,307 individuals. These sample sizes were sufficient to detect
10% changes in the amount of exposure to SHS at the workplaces
or at home (under the least favorable conditions) and a 40%
difference in salivary cotinine concentrations between the two
surveys. Sample size calculations were performed with 5.2
GRANMO MS Windows (http://www.imim.es/media/upload/
arxius/grmw52.zip).
We obtained data and addresses for Barcelona residents from
the updated official city census (years 2001 and 2010) provided by
the Municipal Institute of Statistics of Barcelona. Individuals aged
16 years and older were eligible to participate in the study. A letter
was mailed to eligible individuals to inform them about the
purpose of the study and that they had been selected at random.
The letter also informed them that the study required a visit from
an interviewer that would administer the questionnaire and collect
a saliva sample. The individuals were informed that they were free
to decline participation, and that they could find out more about
the study with a telephone call or email; the contact information
was provided in the letter. Participants that could not be located
after several attempts (at different times of the day and different
days of the week) and those that declined to participate in the
study were replaced at random. The replacements were chosen
from eligible individuals of the same sex, within a 5-year age
group, and within the same district of residence. Substitutions
accounted for 50.7% and 54.6% of the pre- and post-legislation
surveys, respectively. Individuals that agreed to participate were
interviewed at home by trained interviewers. Participants were
asked to sign an informed consent form before proceeding with the
face-to-face interview. In case of subjects aged 16 an 17, parental
written consent was obtained. The same questionnaire was used in
both surveys (on traditional paper in the pre-legislation survey and
in computer-assisted form in the post-legislation survey). Addi-
tional questions were included in the second survey regarding the
smoke-free legislation. The questionnaire included information on
socio-demographics, tobacco consumption, self-assessed exposure
to SHS in different settings (at home, work/educational venues,
during leisure time, and in public and private transportation
vehicles), and attitudes toward smoking restrictions. After com-
pleting the questionnaire, respondents were asked to provide a
sample of saliva for the cotinine analysis, and weight and height
were measured. The Research and Ethics Committee of Bellvitge
University Hospital approved the study protocols and the
informed consent forms, including parental written consent.
Self-reported SHS exposure of non-smokers
Non-smokers were defined as individuals that, at the time of the
interview, reported that they did not smoke, and they had a
salivary cotinine concentration #10 ng/mL [17]. This group
included individuals that had never smoked and ex-smokers.
Exposure to SHS at home was determined with two questions:
‘‘Currently, how many individuals per day usually smoke inside
your home?’’ and ‘‘During the past week, how many cigarettes
(per day) have been smoked in your presence inside your home?’’
Answers were gathered for typical working and non-working days.
Based on these two questions, we derived a dichotomous variable
of exposure to SHS at home: (1) non-exposed individuals, which
included those with no exposure according to answers to both
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questions, and (2) exposed individuals, which included all others.
Exposure to SHS at work or an education venue was determined with two
questions: ‘‘Does anybody smoke in close proximity to you at
work?’’ and ‘‘How many hours per day do you think you are
exposed to tobacco smoke at your education venue?’’ We also
derived a dichotomous variable of exposure to SHS at the
workplace and/or education venue: (1) non-exposed individuals,
which included those with no exposure according to answers to
both questions, and (2) exposed individuals, which included all
others. Exposure to SHS at leisure time was determined with the
question ‘‘How much time have you spent in any place with
tobacco smoke that was not home or work?’’ The answers were
gathered for typical working and non-working days. For analysis,
we derived a dichotomous variable of exposure to SHS during
leisure time: (1) non-exposed individuals, which included those
with no exposure according to the answer to the question, and (2)
exposed individuals, which included all others. Exposure to SHS at
public and private transportation was determined with two questions:
‘‘During the last week, were you in a public transportation vehicle
while someone was smoking?’’ and ‘‘During the last week, were
you in a private transportation vehicle while someone was
smoking?’’ Based on these two questions, we derived a dichoto-
mous variable of exposure to SHS in public and private
transportation vehicles: (1) non-exposed individuals, which includ-
ed those with no exposure according to answers to both questions,
and (2) exposed individuals, which included all others. Exposure to
SHS in any setting was defined as exposure in at least one of the
above mentioned settings.
Salivary cotinine
We asked the participants to provide a saliva sample to
determine the cotinine levels. Cotinine is the main metabolite of
nicotine; it is a stable, specific, sensitive biomarker of tobacco
smoke in biological fluids, with a half-life of 15–17 h, and it reflects
SHS exposure in the last 5–7 days[18]. We followed the same
protocol in both surveys for collecting the saliva sample[6,16].
Briefly, participants were asked to rinse their mouths and then
suck on a lemon candy (SmintR) to stimulate saliva production.
They were asked to provide about 9 mL of saliva by spitting into a
funnel placed in a test tube. The sample was separated into 3 mL
aliquots and frozen at 280uC for storage. The frozen samples
were sent to the Bioanalysis Research Group of IMIM (Hospital
del Mar Medical Research Institute) in Barcelona. Salivary
samples from the pre-legislation survey were analyzed in 2007
with gas chromatography followed by mass spectrometry detection
(GC/MS). The limit of quantification was 1 ng/mL and the limit
of detection was 0.3 ng/mL. Salivary samples from the post-
legislation survey were analyzed in 2012 with liquid chromatog-
raphy coupled with tandem mass spectrometry (LC/MS/MS) with
multiple reaction monitoring. The limit of quantification was
0.1 ng/mL and the limit of detection was 0.03 ng/mL; the
quantification error was ,15%. Because the latter method was
more sensitive and had a lower limit of quantification than the
former method, all available saliva samples from the pre-legislation
survey with cotinine concentrations below 1 ng/mL (n = 245) were
reanalyzed in 2012 with the LC-MS/MS method. The values
from the second analysis were used in the statistical analysis. To
determine the reliability of cotinine values from the pre-legislation
survey, 41 saliva samples with previous values between 1 and
10 ng/mL were chosen at random, and cotinine was assessed with
the LC/MS/MS. This analysis showed very low variation (less
than +/2 1 ng/mL) in the concentration values obtained with
both methods of analysis.
Statistical analysis
We calculated prevalence rates (%) and 95% confidence
intervals (CI) for exposure to SHS among non-smokers in the
different settings. Results were stratified by sex, age (16–44, 45–64,
and $65 years), and educational level (less than primary and
primary school, secondary school, and university). The data were
fitted with multivariate log-binomial models to assess the
prevalence ratios (PR) and 95% CI of exposure to SHS among
non-smokers before and after the implementation of the legisla-
tion. The models were adjusted for sex, age, and educational level.
Geometric means (GM) and geometric standard deviations (GSD)
were computed to describe the cotinine concentrations among
non-smokers, due to its skewed distribution[17,19]. The data were
fitted with generalized linear regression models of the log-
transformed salivary cotinine concentration, adjusted for potential
confounders. We also estimated the percentage changes in salivary
cotinine concentration by comparing the geometric mean of the
concentrations before and after the legislation. Samples with
values below the limit of detection were assigned a value of
0.05 ng/mL (half the limit of detection value). Statistical analyses
were performed with SPSS v17.0 and Stata 10.
Results
Sample
A total of 2,552 participants were interviewed; 1,245 subjects
were in the pre-legislation survey and 1,307 were in the post-
legislation survey. The samples were similar in the proportions of
men and women, but we found significant differences in age and
educational level. 879 (70.6%) participants in the pre-legislation
survey and 947 (72.5%) participants in the post-legislation survey
were self-reported non-smokers. Of the non-smokers, 110 (62 in
the pre-legislation and 48 in the post-legislation surveys) were not
included in the analysis, because they did not provide a saliva
sample; in addition, 12 (10 in the pre-legislation and 2 in the post-
legislation survey) were excluded, because cotinine analysis was
not possible (i.e., insufficient sample). 83 non-smokers from the
pre-legislation survey and 19 from the post-legislation survey were
excluded, because they had cotinine concentrations consistent with
active smoking (.10 ng/mL). Therefore, the final sample for
analysis included a total of 1602 non-smokers; 724 (58.2% of those
interviewed) before the legislation and 878 (67.2% of those
interviewed) after the legislation (Figure 1).
Changes in self-reported exposure to SHS
The prevalence of self-reported exposure to SHS in any setting
fell from 75.7% in 2004–05 to 56.7% in 2011–12 (relative
reduction 225.1, p,0.001) (Table 1); this included reduced
exposures in the home, from 32.5% to 27.6% (215.1%, p,0.05);
at work/education venue, from 42.9 to 37.5 (212.6%, p = 0.11);
during leisure time, from 61.3% to 38.9% (236.5%, p,0.001);
and in public transportation vehicles, from 12.3% to 3.7%
(269.9%, p,0.001). Overall, the prevalence of SHS exposure
declined more sharply among women than among men (29.2% vs.
19.4%, p,0.001). Non-smoking adults between 45 and 64 years
old showed the greatest reduction in the prevalence of SHS
exposure (234.3%, p,0.001); the prevalence in adults aged 65
years or older was reduced by 25.6% (p,0.001), and the
prevalence in adults between 16 and 44 was reduced by 24.6%
(p,0.001) (Appendix S1). The prevalence of exposure to SHS was
reduced to a similar extent for individuals with different
educational levels (Appendix S1). After controlling for sex, age,
and educational level, self-reported exposure to SHS in any setting
after the legislation was significantly reduced (PR: 0.46; 95%CI:
Impact of the Spanish Smoke-Free Legislation
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0.40 to 0.54), including at home, at work/educational venues,
during leisure time, and in public transport vehicles (Table 1).
Changes in salivary cotinine levels
Figure 2 shows the distribution of cotinine values among the
non-smokers before and after legislation. The proportion of non-
smokers with cotinine concentrations below the quantification
limit (0.1 ng/mL) increased from 7.3% (53 samples) before the
legislation to 53.2% (467 samples) after the legislation.
Table 2 compares the geometric mean values of salivary
cotinine concentrations before and after the legislation among
non-smokers. The results are stratified according to socio-
demographic variables. The geometric mean of the cotinine
concentrations among all adult non-smokers fell from 0.93 ng/mL
before the legislation to 0.12 ng/mL (p,0.001) after the
legislation. After adjusting for sex, age, and educational level,
the reduction in cotinine concentration was 87.6% (p,0.001). The
adjusted reduction in cotinine concentration after the implemen-
tation of the law was similar for participants of all ages. However,
adult non-smokers with a university education showed the greatest
adjusted reduction in cotinine concentration (Table 2).
Discussion
This was the first study to evaluate using both self-reports and a
personal biomarker of exposure to SHS the impact of the stepped
Spanish smoke-free legislation (laws 28/2005 and 42/2010) on
SHS exposure in different settings among adult non-smokers from
the general population. We found that self-reported exposure to
SHS and salivary cotinine levels significantly decreased after the
implementation of the legislation. This reduction was observed at
workplaces, during leisure time, and even in settings not regulated
by the law, like in the home and public transportation.
Self-reported second-hand smoke exposure
The reduction in SHS exposure between 2004–05 and 2011–12
was greater for women than men and for individuals aged 45 to 64
compared with other age groups. Haw and Gruer[20] also
evaluated changes in self-reported exposure to SHS among adult
non-smokers after the implementation of smoke-free legislation in
Scotland. They found that, after legislation, self-reported SHS
exposure fell for all the settings assessed. Similarly, we observed a
25.1% reduction in SHS exposure among participants exposed in
any setting. However, we are not able to distinguish the effects of
the first (28/2015) and second (42/2010) bans on the reductions
observed. Previous evaluations of the 28/2005 law showed
important reductions in the exposure to SHS at the workplace[8],
but that law did not affect the exposure to SHS at home or during
leisure time[9,11] nor in bars or restaurants[8,10]. In the present
study, the highest reductions in self-reported SHS exposure were
observed in public transportation vehicles and during leisure time.
Data from another study in Spain showed that both airborne
nicotine and PM2.5 decreased by more than 90% in bars and
restaurants after the implementation of law 42/2010[14]. At the
population level, a reduction in the self-reported exposure to SHS
during leisure time after 2010 has been also oberved in
Galicia[11]. Those results and the results obtained in the present
study demonstrated the importance of the new legislation (Law
42/2010), which extended the prohibition of smoking to all
hospitality venues without exception. These venues were places
where young, adult non-smokers were mostly exposed during their
leisure time. We also observed a significant relative reduction
(15.1%) in the home, which confirmed no displacement of
smoking to this setting but an unexpected positive side-effect of
the smoke-free legislation. This finding agreed with other previous
studies performed at the individual level[20–24] and at the
ecological level[25]. We found a 12.6% reduction in self-reported
exposure to SHS at work and educational venues. Previous studies
in Spain[9,11] showed greater reductions in self-reported exposure
at work between 2005 and 2006. However, our results were
consistent with another study,[5] which showed that 39.8% of
non-smokers were exposed to SHS at work and educational
venues after the implementation of Law 28/2005 (which
prohibited smoking in the workplace, but not hospitality venues).
Cotinine concentrations
The proportion of non-smokers that had undetectable cotinine
concentrations increased from 7.3% before the 28/2005 law to
53.2% after the implementation of the 42/2010 law. Our results
confirmed the positive impact of smoke-free laws on SHS exposure
at the population level. For example, after legislation, in New
York, Bauer et al.[26] found an increase in the proportion of
respondents with cotinine concentrations below the detection limit
(from 32.5% to 52.4%); in Scotland, Haw and Gruer[20] also
observed an increase in individuals with undetectable cotinine
(from 11.3% to 27.6%); and, in England, Sims et al.[27] found
that the odds of having undetectable cotinine were 1.5 times
higher than before the legislation.
In addition to this shift in the distribution of the non-smoking
population towards lower levels of cotinine, the mean concentra-
tion declined from 0.93 ng/mL to 0.12 ng/mL (adjusted reduc-
tion of 87.6%). This reduction in cotinine concentration was
greater than those obtained after the implementation of smoke-free
Figure 1. Flow chart with the sample selection in both surveys
(PRE: 2005–06 and POST: 2011–12) and exclusions from the
initial sample. Footnote to Figure 1. From the initial sample in each
survey, we excluded people who declared to be smokers and people
,16 years old. Among people who declared to be non-smokers, we
excluded those with unreliable cotinine levels for non-smokers (this is,
they had smoked at the time of the interview). We also excluded people
who did not provide the saliva sample or in which the cotinine analysis
was not possible because of insufficient sample or technical error.
doi:10.1371/journal.pone.0089430.g001
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Table 1. Self-reported exposure to secondhand smoke in non-smokers before (2004–05) and after (2011–12) the smoke-free
legislation, Barcelona, Spain; results are stratified by setting.
Self-reported exposure to secondhand smoke n
% of non-smokers exposed (95%
CI) Prevalence ratio* (95% CI)
Any setting**
Before the legislation 720 75.7 (72.6–78.8) 1
After the legislation 871 56.7 (53.4–60.0) 0.46 (0.40 to 0.54)
Home**
Before the legislation 721 32.5 (29.1–35.9) 1
After the legislation 878 27.6 (24.6–30.6) 0.78 (0.65 to 0.94)
Work/education venues**
Before the legislation 364 42.9 (37.8–48.0) 1
After the legislation 507 37.5 (33.3–41.7) 0.79 (0.63 to 0.98)
Leisure time**
Before the legislation 723 61.3 (57.7–64.9) 1
After the legislation 872 38.9 (35.7–42.1) 0.38 (0.32 to 0.44)
Public transportation **
Before the legislation 626 12.3 (9.7–14.9) 1
After the legislation 669 3.7 (2.3–5.1) 0.26 (0.16 to 0.41)
Private transportation**
Before the legislation 585 9.4 (7.0–11.8) 1
After the legislation 616 10.7 (8.3–13.1) 0.97 (0.67 to 1.41)
*Based on multivariate log-binomial models, adjusted for sex, age, and educational level.
**The figures do not sum the total because of missing values.
doi:10.1371/journal.pone.0089430.t001
Figure 2. Distribution of salivary cotinine concentrations (ng/mL) among the non-smoker adult population, before (2004–05) and
after (2011–12) the smoke-free legislation, in Barcelona, Spain.
doi:10.1371/journal.pone.0089430.g002
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legislation in New York[26], Scotland[20], and England[27] (reduc-
tions of 47%, 39%, and 27%, respectively). The larger decrease in
Spain might be explained by the fact that the salivary cotinine
concentrations among non-smokers in our study (0.93 ng/mL) before
the 28/2005 legislation was 2 to 9 times higher than salivary cotinine
concentrations obtained in New York[26], England[27], and Scot-
land[20] before the smoke-free bans (0.078 ng/mL, 0.14 ng/mL, and
0.43 ng/mL, respectively); the post-legislation concentrations were
similar in the four different populations. In the absence of smoke-free
legislation, the higher salivary cotinine levels in Spain among non-
smokers (higher SHS exposure) could be explained by the higher
prevalence of smoking in the population. After the implementation of
smoke-free legislation, SHS exposure would decrease, regardless of the
prevalence of smoking.
Strengths and limitation of the study
One potential limitation of the study was an information bias
derived from the use of a questionnaire. Self-reported, adult non-
smokers represented 70.6% of the participants interviewed in the
pre-legislation survey and 72.5% in the post-legislation survey.
These prevalences were consistent with data from the 2006 and
2011 Spanish National Health Interview Surveys (Ministerio de
Sanidad y Consumo: Encuesta Nacional de Salud 2006, 2013).
This limitation was reduced by using an objective, specific
biomarker of SHS exposure, and by asking the participants about
their exposure in both private and public places, including the
home, work/educational venues, leisure venues, and transporta-
tion vehicles. Thus, we covered the primary settings where SHS
exposure can occur.
Another limitation is that we did not have data after the first law
and previous to the second law, thus preventing us to elucidate the
separate effects of both laws, as would have been of great interest
given the stepped nature of the Spanish smoke-free legislation.
However, the interpretation of our results together with the
previous studies focused on the first law allows to globally
evaluating the effects of the Spanish smoke-free laws.
This was a repeated cross-sectional study, which was potentially
more likely to be biased than a longitudinal study. However,
longitudinal studies can be subject to some bias, due to the loss of
participants in the follow-up, which reduces its advantages.
Nevertheless, repeated cross-sectional surveys that include a
biological marker have been shown to be a valid method for
evaluating smoke-free legislation[18,28,29].
This study included representative, random samples of the
population of Barcelona (Spain) and it evaluated the impact of smoke
free legislation on exposure to SHS with a combination of self-reported
exposure and cotinine as an objective biomarker of SHS exposure. To
minimize differences between the two collection periods, we used the
same strategy in collecting the pre and post legislation data.
Additionally, the fieldwork was performed during different days of
the week, including weekends, and in different months to avoid
systematic biases due to potential seasonal and timing aspects of data
collection. The method for analyzing cotinine in the post legislation
survey was more sensitive and had a lower limit of quantification than
that used in the pre legislation survey. However, we reanalyzed the
samples in the pre-legislation survey with the new method, and found
satisfactory agreement in the results. Individuals that declined to
participate were replaced at random with individuals with the same
characteristics to prevent problems with sample size and selection
biases. Although we had a high percentage of substitutions in both
surveys, we obtained a high percentage of non-smokers that provided
saliva samples in the pre- and post- legislation surveys (92.9% and
94.9%, respectively); this proportion was higher than those observed in
similar assessments in Scotland (64.8% and 63.1%, respectively) [20]
and in New York (33%, overall)[26].
Conclusions
This study showed that the implementation of a stepped smoke-
free legislation (laws 28/2005 and 42/2010) was accompanied by a
large reduction in SHS, both self-reported and assessed by means
of salivary cotinine levels, in the adult non-smoking population in
Table 2. Change in the geometric means of salivary cotinine concentrations (ng/mL) before (2004–05) and after (2011–12) the
smoke-free legislation, Barcelona, Spain; results are stratified according to socio-demographic variables.
Before legislation After legislation
Percentage of change* (95%
CI)
N GM (GSD) (ng/mL) N GM (GSD) (ng/mL)
All subjects 724 0.93 (4.01) 878 0.12 (3.12) 87.6 (76.7–102.0)
Sex
Men 296 1.11 (3.65) 380 0.12 (2.91) 89.4 (80.6–102.1)
Women 428 0.82 (4.22) 498 0.12 (3.28) 86.1 (74.4–102.7)
Age (years)**
16–44 236 1.00 (3.66) 361 0.12 (3.09) 88.0 (78.1–102.7)
45–64 234 0.82 (4.17) 254 0.13 (3.18) 85.4 (73.9–104.1)
$65 251 0.98 (4.19) 263 0.11 (3.10) 89.2 (80.6–102.9)
Educational level**
Less than primary and primary 342 0.87 (4.16) 236 0.12 (3.27) 86.1 (79.4–103.5)
Secondary 132 0.97 (3.95) 341 0.14 (3.28) 85.2 (73.7–104.3)
University 249 0.98 (3.83) 300 0.10 (2.75) 90.2 (82.2–102.1)
GM: Geometric mean.
GSD: Geometric standard deviation.
*Based on the adjusted geometric mean derived from a generalized linear model that included all the variables in the table.
**The figures do not sum the total because of missing values.
doi:10.1371/journal.pone.0089430.t002
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Barcelona, Spain. The strategy of strengthening Law 28/2005 to
hospitality venues without exceptions was clearly effective. We
observed a high reduction in SHS exposure during leisure time,
and a reduction in SHS exposure at home contrary to the
speculative tobacco industry hypothesis of displacement of
smoking from public to private places. Based on the results of
this study, comprehensive tobacco control policies were effective in
reducing SHS exposure. Thus, over time, the law will result in a
reduction in morbidity and mortality among nonsmoking adults.
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